Terpenes and derivatives as a new perspective for pain treatment: a patent review

被引:99
作者
Guimaraes, Adriana G. [1 ]
Serafini, Mairim R. [2 ]
Quintans-Junior, Lucindo J. [3 ]
机构
[1] Univ Fed Sergipe, Dept Hlth Educ, Sao Cristovao, Brazil
[2] Univ Fed Sergipe, Ctr Pharm, Lagarto, SE, Brazil
[3] Univ Fed Sergipe, Dept Physiol, Sao Cristovao, Sergipe, Brazil
关键词
analgesia; drugs; nociception; pain; terpene; terpenoid; NATURAL-PRODUCTS; DOUBLE-BLIND; DRUG; MONOTERPENES;
D O I
10.1517/13543776.2014.870154
中图分类号
R914 [药物化学];
学科分类号
100701 ;
摘要
Introduction: Terpenes are natural compounds found in several organisms belonging to the animal and plant kingdoms. They constitute the largest class of natural products with > 55,000 known compounds structurally diversified. Several studies have attributed to this big family of compounds a range of pharmacological properties, such as anticancer, antimicrobial, antifungal, antiviral, antihyperglycemic, analgesic, anti-inflammatory and antiparasitic. Areas covered: In this review, the authors summarize therapeutic patent applications concerning the employment of terpenes for pain relief, focusing on the perspective for these compounds to become candidates for new drugs intended to control painful syndromes. Expert opinion: Over years of tremendous academic and industrial investment in the characterization of the analgesic action of terpenes, there was the development of a successful product that has been well-accepted clinically. Furthermore, there is still hope that new therapeutic options for the control of painful syndromes will be developed from terpenes, which have been shown to be great candidates for this purpose because of the range of pharmacological mechanisms in important target sites.
引用
收藏
页码:243 / 265
页数:23
相关论文
共 61 条
[1]   Synthesis and quantitative structure-activity relationship study of substituted imidazophosphor ester based tetrazolo[1,5-b] pyridazines as antinociceptive/anti-inflammatory agents [J].
Abdou, Wafaa M. ;
Ganoub, Neven A. ;
Sabry, Eman .
BEILSTEIN JOURNAL OF ORGANIC CHEMISTRY, 2013, 9 :1730-1736
[2]   Cannabinergic Pain Medicine A Concise Clinical Primer and Survey of Randomized-controlled Trial Results [J].
Aggarwal, Sunil K. .
CLINICAL JOURNAL OF PAIN, 2013, 29 (02) :162-171
[3]  
Amazonia Fitomedicamentos LTDA, 2011, Pharmaceutical uses of lanosta-8,24-dien-3-ols, Patent No. [MX001411, 001411]
[4]   Cellular and Molecular Mechanisms of Pain [J].
Basbaum, Allan I. ;
Bautista, Diana M. ;
Scherrer, Gregory ;
Julius, David .
CELL, 2009, 139 (02) :267-284
[5]  
Biotechnology Res Corp, 2011, Triterpenoid compounds and methods of use thereof, Patent No. [US288169, 288169]
[6]  
BMB Patent Holding Corp, 2008, Patent No. [WO052183, 052183]
[7]   The Pharmacologic and Clinical Effects of Medical Cannabis [J].
Borgelt, Laura M. ;
Franson, Kari L. ;
Nussbaum, Abraham M. ;
Wang, George S. .
PHARMACOTHERAPY, 2013, 33 (02) :195-209
[8]  
Bothma Zelpy 2549 Ltd, 2007, Compositions comprising sesquiterpene compounds for use in the Prophylaxis or treatment of pain, Patent No. [WO066305, 066305]
[9]   Twenty-five years of research on medicinal plants in Latin America - A personal view [J].
Calixto, JB .
JOURNAL OF ETHNOPHARMACOLOGY, 2005, 100 (1-2) :131-134
[10]  
Center Pharmaceutical Chemistry, 2000, Compositions obtained from Mangifera indica L, Patent No. [WO038699, 038699]